Thank you for being part of EMERGE 2050!

OVER $1 BILLION IN FUNDS AVAILABLE TO HEALTH TECH INNOVATORS AT EMERGE 2050

Stay tuned for more updates about the 2025 edition.

1,000+

Visitors

1

World-class conference

15

Healthtech, medtech & biotech startups

80%

C-suite attendees

OVER US$1 BILLION IN FUNDS AVAILABLE TO HEALTHCARE INNOVATORS AT EMERGE 2050!

  • EMERGE 2050 is dedicated to innovations in healthtech, medtech and biotech, providing disruptors in start-up and growth stage, the chance to meet investors.

  • As well as being able to pitch the venture capitalists, our disruptors have the opportunity to speak in the event’s main stage program, to address healthcare providers and payers, and to talk about the role they see their ideas taking in cost saving and greater efficiency in the sector.
  • The event takes place alongside PrecisionMed Exhibition & Summit on 8 – 9 May 2024 in Sheikh Rashid Hall at the Dubai World Trade Centre.
  • This year we have introduced “The Nest”, a dedicated area for innovators to display products and pitch their concepts to the cross section of stakeholders in attendance.
  • The EMERGE 2050 Main Stage features engaging talks and panel discussions by industry experts about healthcare investment trends, market access, how to gain funding and more. The innovations programme features pitches by healthtech, medtech and biotech start-ups looking for their next growth stage through investment. Join the conversation and stay up to date on the latest in healthcare technology and investment

Key 2024 speakers

Edward Kliphuis

Partner,
Sofinnova Partners

Marwan Abdulaziz

Managing Director,
Dubai Science Park

H.E Mariam AlMazrouei

Advisor, Department of Health Abu Dhabi

Rana Lonnen

Managing Director,
Novartis dRx Capital

Dr. Sarper Tanli

Managing Director, MEA; Global Advisory, Mass General Brigham

Willem Baralt

Portfolio Chairman & Board Director

Mussaad Al Razouki

Operating Partner, Deerfield Management

Paolo Di Giorgio

CEO & Managing Director, Angelini Ventures

Sarah Miller

Founder,
MDBX Health

Hany Elosman

Director of Technology of AI,
NEOM

Rasha Taifi

Venture Capitalist Turned Innovation Consultant

Mariam Al Harbi, MD

Chair of Research Ethics Committee, SEHA

Kawthar Bukhari

Partner Success Manager – Health,
Plug and Play Tech Center

Jan Szollos

Senior Director, Insilico Medicine

Dr. Ahmad Nasrallah

CEO,
Dar Al Shifa Hospital, Kuwait

Joe Hawayek

CEO, Diginova Health Solutions

Cedric Odje

Senior Associate, Debiopharm Innovation Fund

Rania Haggag

Pharmacoviglance Lead, Organon

Vincent Buscemi

Partner and Head of Independent Health and Care, Bevan Brittan

Perihan Abouzeid

CEO, Peri-Care

Vaibhav Kashyap

CEO, Wellx

Dina Sidani

Founder, Ilik Health

Nik Sharma

CEO and co-founder,
Biocortex

Gireesh Kumar

Sector Lead & Associate Partner, Healthcare Sector, Knight Frank Middle East

Mansoor Ahmed

Executive Director – MEA Region,
Colliers

Caroline Souchet

Investment Manager, Crescent Enterprises

Dr. Sadyk Gusniev, MD, MBA

Healthtech Expert and Researcher

Dr. Altaf Faiyaz

Associate Director – Healthcare, Education & PPP, Coliers MENA

Robert Mcgough

Partner,
Hill Dickinson LLP

Miro Fok

Founder,
Vita Virtues

Pilar Fernandez Hermida

Founder,
i-Expand

Vikash Sharma

Group CEO,
Avisa Smart Hospitals

Sophie Smith

Founder & CEO,
Nabta Health

Reenita Das

Partner,
Frost & Sullivan

Arnoud Huisman

CEO and Chairman of the Board,
Oncode Accelerator

Kareem Barghouti

Co-Founder & CEO,
PragmaBio

Ayman Semaan

Market Access & Pricing Lead,
Biologix

Marielouise Abi Hanna

Founder and Executive Director,
Creaiviti

Desiree Cox

CEO and Founder,
The HEALinc

Key innovators

Khatija Ali

Founder and CEO,
Biosapien

Christopher Cook

Founder,
iavai

Hossein Fakhrai-Rad

Founder,
Healthasion

Toby Wilson Waterworth

Chair and Chief Executive, Ambrose Healthcare

Ashraf Bacheet

CEO & Co-Founder,
O7 Therapy

Pouya Behrouzi

Co-Founder & CEO,
Rayca Precision

Alina Polyakova

Founder, Mamahood.app

Devayani Clark

HealAI

Osama Chamsi Pasha

Co-Founder & COO, Doctory

Roland Quaye

CEO & Founder,
Latenu LLC

WHY SHOULD YOU ATTEND?

Innovators

Revel in a setting with a high concentration of capital. Investors with a combined value of US$1+ billion in funds will be onsite to meet companies like yours. Pitch your idea. Meet with the teams behind the money. Find the capital and partnering to take your idea forward.

InvestorS

A multitude of early stage and growth stage innovators present and in circulation. Rub shoulders with peers and associates in life science investment. Whether or not you are already engaged and doing business in the Middle East, this is a superb opportunity to network and tap into emerging opportunities. Engage multiple stakeholders, find new innovation, establish investment for future funds.

payers & healthcare providers

Under the theme “Taking the cost out of healthcare”, key marketplace professionals will take the stage to discuss what’s next. Speakers include a broad eco system of actors including government regulators, payers and insurers, investors, innovators, CFOs and heads of business and specialist media leaders.

who attends emerge 2050

Healthtech, medtech & biotech startups
37%
Investors
24%
Leaders from the healthcare industry
23%
Insurers and pharmaceutical delegates
10%
Medical professionals
6%

Featured innovators and partners

Featured investors

“This show is absolutely amazing”

Jeffrey Stephens, Chief Investment Officer, Infusion 51a LP

Co-located with PrecisionMed Exhibition & Summit 2024

The 3rd edition of PrecisionMed Exhibition & Summit (PMES) takes place in May 2024. PMES aims to welcome over 7,000 healthcare professionals including doctors, disease specialists, laboratory heads, researchers, as well as senior roles from reseller and distributor organisations, government, innovators and investors, and others interested in the latest development in personalised care.

Find out more.

“This show is absolutely amazing”

Jeffrey Stephens, Chief Investment Officer, Infusion 51a LP